UK drug firm Shire to buy US rival in $5.2bn deal

UK pharmaceutical company Shire has clinched a deal to buy US biotech firm NPS Pharmaceuticals for $5.2bn (£3.4bn). Shire said the deal would strengthen its position in the lucrative field of medicines for rare diseases. via Pocket http://ift.tt/1If7u7u